| 技术与方法 |
|
|
|
|
| 运用BioID技术筛选S100A7互作蛋白* |
王俊豪,孔菲,李允广,刘进,胡恩泽,王睿,黄凌云**( ),肖雪媛**() |
| 北京师范大学生命科学学院 细胞增殖及调控生物学教育部重点实验室 北京 100875 |
|
| Screening of S100A7 Interacting Proteins Using BioID Technology |
| WANG Jun-hao,KONG Fei,LI Yun-guang,LIU Jin,HU En-ze,WANG Rui,HUANG Ling-yun**(),XIAO Xue-yuan**() |
| Key Laboratory of Cell Proliferation and Regulation Biology of Ministry of Education,College of Life Sciences, Beijing Normal University, Beijing 100875, China |
引用本文:
王俊豪,孔菲,李允广,刘进,胡恩泽,王睿,黄凌云,肖雪媛. 运用BioID技术筛选S100A7互作蛋白*[J]. 中国生物工程杂志, 2022, 42(8): 52-62.
WANG Jun-hao,KONG Fei,LI Yun-guang,LIU Jin,HU En-ze,WANG Rui,HUANG Ling-yun,XIAO Xue-yuan. Screening of S100A7 Interacting Proteins Using BioID Technology. China Biotechnology, 2022, 42(8): 52-62.
链接本文:
https://manu60.magtech.com.cn/biotech/CN/10.13523/j.cb.2203048
或
https://manu60.magtech.com.cn/biotech/CN/Y2022/V42/I8/52
|
| [1] |
Varnaitė R, MacNeill S A. Meet the neighbors: mapping local protein interactomes by proximity-dependent labeling with BioID. Proteomics, 2016, 16(19): 2503-2518.
doi: 10.1002/pmic.201600123
pmid: 27329485
|
| [2] |
Choi-Rhee E, Schulman H, Cronan J E. Promiscuous protein biotinylation by Escherichia coli biotin protein ligase. Protein Science, 2004, 13(11): 3043-3050.
pmid: 15459338
|
| [3] |
Roux K J. Marked by association: techniques for proximity-dependent labeling of proteins in eukaryotic cells. Cellular and Molecular Life Sciences, 2013, 70(19): 3657-3664.
doi: 10.1007/s00018-013-1287-3
|
| [4] |
Roux K J, Kim D I, Raida M, et al. A promiscuous biotin ligase fusion protein identifies proximal and interacting proteins in mammalian cells. The Journal of Cell Biology, 2012, 196(6): 801-810.
doi: 10.1083/jcb.201112098
|
| [5] |
Kim D I, Birendra K C, Zhu W H, et al. Probing nuclear pore complex architecture with proximity-dependent biotinylation. Proceedings of the National Academy of Sciences of the United States of America, 2014, 111(24): E2453-E2461.
|
| [6] |
Comartin D, Gupta G D, Fussner E, et al. CEP120 and SPICE 1 cooperate with CPAP in centriole elongation. Current Biology, 2013, 23(14): 1360-1366.
doi: 10.1016/j.cub.2013.06.002
pmid: 23810536
|
| [7] |
Firat-Karalar E N, Stearns T. Probing mammalian centrosome structure using BioID proximity-dependent biotinylation. Methods in Cell Biology, 2015, 129: 153-170.
doi: S0091-679X(15)00102-8
pmid: 26175438
|
| [8] |
Couzens A L, Knight J D R, Kean M J, et al. Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions. Science Signaling, 2013, 6(302): rs15.
|
| [9] |
Kim D I, Jensen S C, Noble K A, et al. An improved smaller biotin ligase for BioID proximity labeling. Molecular Biology of the Cell, 2016, 27(8): 1188-1196.
doi: 10.1091/mbc.E15-12-0844
|
| [10] |
Madsen P, Rasmussen H H, Leffers H, et al. Molecular cloning, occurrence, and expression of a novel partially secreted protein "psoriasin" that is highly up-regulated in psoriatic skin. The Journal of Investigative Dermatology, 1991, 97(4): 701-712.
doi: 10.1111/1523-1747.ep12484041
|
| [11] |
Emberley E D, Murphy L C, Watson P H. S100A7 and the progression of breast cancer. Breast Cancer Research: BCR, 2004, 6(4): 153-159.
doi: 10.1186/bcr816
|
| [12] |
Alowami S, Qing G F, Emberley E, et al. Psoriasin (S100A7) expression is altered during skin tumorigenesis. BMC Dermatology, 2003, 3: 1.
pmid: 12600274
|
| [13] |
Kataoka K, Ono T, Murata H, et al. S100A 7 promotes the migration and invasion of osteosarcoma cells via the receptor for advanced glycation end products. Oncology Letters, 2012, 3(5): 1149-1153.
pmid: 22783409
|
| [14] |
Fukuzawa H, Kiyoshima T, Kobayashi I, et al. Transcription promoter activity of the human S100A 7 gene in oral squamous cell carcinoma cell lines. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression, 2006, 1759(3-4): 171-176.
doi: 10.1016/j.bbaexp.2006.03.004
|
| [15] |
Kong F, Li Y G, Hu E Z, et al. The characteristic of S100A 7 induction by the hippo-YAP pathway in cervical and glossopharyngeal squamous cell carcinoma. PLoS One, 2016, 11(12): e0167080.
doi: 10.1371/journal.pone.0167080
|
| [16] |
Li Y G, Kong F, Shao Q R, et al. YAP expression and activity are suppressed by S100A7 via p65/NFκB-mediated repression of ΔNp63. Molecular Cancer Research: MCR, 2017, 15(12): 1752-1763.
doi: 10.1158/1541-7786.MCR-17-0349
|
| [17] |
Brandherm I, Disse J, Zeuschner D, et al. cAMP-induced secretion of endothelial von Willebrand factor is regulated by a phosphorylation/dephosphorylation switch in annexin A2. Blood, 2013, 122(6): 1042-1051.
doi: 10.1182/blood-2012-12-475251
pmid: 23757730
|
| [18] |
de Graauw M, Tijdens I, Smeets M B, et al. Annexin A2 phosphorylation mediates cell scattering and branching morphogenesis via cofilin Activation. Molecular and Cellular Biology, 2008, 28(3): 1029-1040.
doi: 10.1128/MCB.01247-07
pmid: 18070928
|
| [19] |
Lokman N A, Elder A S F, Ween M P, et al. Annexin A2 is regulated by ovarian cancer-peritoneal cell interactions and promotes metastasis. Oncotarget, 2013, 4(8): 1199-1211.
doi: 10.18632/oncotarget.1122
pmid: 23945256
|
| [20] |
Cui H Y, Wang S J, Miao J Y, et al. CD147 regulates cancer migration via direct interaction with Annexin A2 and DOCK3-β-catenin-WAVE2 signaling. Oncotarget, 2016, 7(5): 5613-5629.
doi: 10.18632/oncotarget.6723
|
| [21] |
Jia J W, Li K L, Wu J X, et al. Clinical significance of annexin II expression in human non-small cell lung cancer. Tumor Biology, 2013, 34(3): 1767-1771.
doi: 10.1007/s13277-013-0715-1
|
| [22] |
Moreau K, Ghislat G, Hochfeld W, et al. Transcriptional regulation of Annexin A 2 promotes starvation-induced autophagy. Nature Communications, 2015, 6: 8045.
doi: 10.1038/ncomms9045
pmid: 26289944
|
| [23] |
Lokman N A, Pyragius C E, Ruszkiewicz A, et al. Annexin A2 and S100A10 are independent predictors of serous ovarian cancer outcome. Translational Research, 2016, 171: 83-95.e2.
doi: 10.1016/j.trsl.2016.02.002
pmid: 26925708
|
| [24] |
王英, 赵晓航. Psoriasin(S 100A7)蛋白的结构与功能. 癌症进展, 2003, 1(1): 10-13.
|
|
Wang Y, Zhao X H. The structure and functions of psoriasin (S 100A7). Oncology Progress, 2003, 1(1): 10-13.
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
| |
Shared |
|
|
|
|
| |
Discussed |
|
|
|
|
